Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Transmission and infection of H5N1 Stories

Canada Confirms First H5N1 Bird Flu Case, Death In North America
2014-01-10 06:17:59

Lawrence LeBlond for redOrbit.com - Your Universe Online A strain of avian influenza that has sickened nearly 650 people in China and neighboring regions has now been confirmed in North America. The H5N1 bird flu strain, which has also killed 385 people worldwide, was discovered on January 1, 2014 in a Canadian tourist who had recently returned from China. The patient, who died on January 3 due to complications of the illness, had been in China from Dec 6 through 27 and was symptomatic...

2013-10-21 12:27:44

Bioradar UK Ltd. Cautions Against Relaxing Public Health Measures Given Four-Month Lag in Available Data, Lessons from SARS LILLE, France, Oct. 21, 2013 /PRNewswire/ -- Bioradar UK Ltd. announced today at the Vaccine Congress Europe in Lille that quantitative real-time Replikins Analysis of the virus genome of lethal Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) shows that the percent of the virus' genomic Replikins Counts greater than 4.0 per 100 amino acids has dropped...

Human-To-Human Transmissibility Discovered In H7N9 Bird Flu
2013-08-07 07:08:55

Lawrence LeBlond for redOrbit.com - Your Universe Online A team of Chinese researchers has discovered the first probable case of human to human transmission of H7N9 bird flu in China. While the news is startling, the researchers still stress that it does not spread efficiently in this manner. Published today in the British Medical Journal, the study findings provide the strongest evidence yet of H7N9 transmission between humans, a disease that has so far sickened 134 people and resulted...

2013-07-16 14:10:45

Some strains of the avian H7N9 influenza that emerged in China this year have developed resistance to the only antiviral drugs available to treat the infection, but testing for antiviral resistance can give misleading results, helping hasten the spread of resistant strains. The authors of a study published in mBio®, the online open-access journal of the American Society for Microbiology, characterized viruses taken from the first person known to be stricken with H7N9 influenza and found...

2013-07-02 11:20:35

H7N9 pneumonia is characterized by imaging findings that differentiate it from other types of pneumonia, including rapidly progressive changes in the lungs and pulmonary connective tissues, according to the first study to describe radiologic findings in the disease. The results are published online in the journal Radiology. "The severity of these findings is associated with the severity of the clinical condition of the patients," said study co-author Zhiyong Zhang, M.D., Ph.D., from the...

2013-01-22 08:31:27

BOSTON, Jan. 22, 2013 /PRNewswire/ -- Replikins Ltd. and Brain Research Associates announced today that specific conserved genomic Replikin peptide sequences for the first time have been found to be shared among different histological cancer types, permitting the seven day synthesis of new shared cancer vaccines. (Photo: http://photos.prnewswire.com/prnh/20130122/PH45996 ) Each of the shared Replikins was found to be present in multiple malignancies. The genomic Replikin(®)Count (number...

Canine Virus Could Help In Development Of Human Vaccines
2012-11-28 08:46:45

Connie K. Ho for redOrbit.com — Your Universe Online Dogs are known to be man´s best friend. However, on closer inspection, canines could provide even more than friendly companionship and become a gateway to infection protection. In particular, researchers from the University of Georgia (UGA) recently revealed that a common virus found in dogs could possibly help develop novel vaccines to treat fatal human diseases. The virus, known as a parainfluenza virus 5 (PIV5), is...

2012-11-20 08:26:41

- First Demonstration of Cross-Protection Against H2N2 Influenza and a Different H5N1 Strain - QUEBEC CITY, Nov. 20, 2012 /PRNewswire/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced results from an independent preclinical study on the cross-protection effects of Medicago's H5N1 VLP vaccine candidate...

2012-10-09 20:40:59

Renowned virus experts address the moratorium on potentially hazardous H5N1 influenza research Last winter, scientists at the University of Wisconsin and Erasmus University (Netherlands) shocked the world by announcing they had developed strains of H5N1 influenza that could easily pass between mammals (ferrets). In nature, H5N1 is extremely lethal (kills nearly 60% of its human cases), but it does not easily spread from person-to-person. Thus, biosafety concerns were raised over the...

2012-09-10 06:29:58

MERIDEN, Conn., Sept. 10, 2012 /PRNewswire/ -- Protein Sciences Corporation announced that this afternoon there will be a presentation of clinical data for the pandemic (monovalent) formulation of Protein Sciences innovative solution for protection from influenza, FluBlok, by John Treanor, MD, Chief of the Infectious Diseases Division of the Department of Medicine at the University of Rochester Medical Center. The presentation will occur at the Interscience Conference on Antimicrobial Agents...